Calcium antagonists in the olfactory bulbectomy animal model of depression: Effect on the cortical NMDA receptor complex

Polish Journal of Pharmacology

Volumn 48, Issue 2, 1996, Pages 137-143

  Nowak, Gabriel ^a,b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Calcium channel antagonists; Diltiazem; Glycine sites; Hyperactivity; NMDA receptor; Olfactory bulbectomy; Verapamil

Indexed keywords

5,7 DICHLOROKYNURENIC ACID; CALCIUM ANTAGONIST; CALCIUM CHANNEL; DILTIAZEM; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RADIOLIGAND; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DEPRESSION; DRUG RECEPTOR BINDING; ELECTRIC POTENTIAL; HYPERACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; OLFACTORY BULBECTOMY; OPEN FIELD BEHAVIOR; RAT;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CEREBRAL CORTEX; DEPRESSION; DILTIAZEM; EXCITATORY AMINO ACID ANTAGONISTS; GLYCINE; KYNURENIC ACID; MALE; MOTOR ACTIVITY; OLFACTORY BULB; PROTEIN BINDING; RADIOACTIVE TRACERS; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; TRITIUM; VERAPAMIL;

EID: 0030056674     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bredt D. S., Snyder S. H.: Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Nat. Acad. Sci. USA, 1989, 86, 9030-9033.
2. Cairncross K. D., Wren A. F., Cox B., Schnieden H.: Effects of olfactory bulbectomy and domicile on stress induced corticosterone release in the rat. Physiol. Behav., 1977, 19, 485-487.
3. Carter A. J.: Glycine antagonists: regulation of the NMDA receptor-channel complex by the strychnine-insensitive glycine site. Drugs of the Future, 1992, 17, 595-613.
4. Courtney M. J., Lambert J. J., Nicholls D. G.: The interactions between plasma membrane depolarization and glutamate receptor activation in the regulation of cytoplasmic free calcium in cultured cerebral granule cells. J. Neurosci., 1990, 10, 3873-3879.
5. Czyrak A., Mogilnicka E., Maj J.: Dihydropyridine calcium channel antagonists as antidepressant drugs in mice and rats. Neuropharmacology, 1989, 3, 229-233.
6. 3H]MK 801 binding to mouse brain sections. Eur. J. Pharmacol. - Molec. Pharm., 1994, 269, 325-330.
7. Geoffroy M., Mogilnicka E., Nielsen M., Rafaelsen O. J.: Effect of nifedipine on the shuttlebox escape deficit induced by inescapable shock in the rat. Eur. J. Pharmacol., 1988, 154, 277-283.
8. Höschl C.: Do calcium antagonists have a place in the treatment of mood disorders. Drugs, 1991, 42, 721-729.
9. Höschl C., Koženy J.: Verapamil in affective disorders: a controlled, double-blind study. Biol. Psychiat., 1989, 25, 128-140.
10. Kitamura Y., Zhao X.-H., Takei M., Yonemitsu O., Nomura Y.: Effects of antidepressants on the glutamatergic system in mouse brain. Neurochem. Int., 1991, 3, 247-253.
11. Kleckner N. W., Dingledine R.: Requirement for glycine in activation of NMDA-receptors expressed in VL - Xenopus oocytes. Science, 1988, 241, 835-837.
12. Kostowski W., Dyr W., Pucilowski O.: Activity of diltiazem and nifedipine in some animal models of depression. Pol. J. Pharmacol. Pharm., 1990, 42, 121-127.
13. Kutsuwada T., Kashiwabuchi N., Mori S., Araki K., Meguro H., Masaki H., Kumanishi T., Arakawa M., Mishina M.: Molecular diversity of the NMDA receptor channel. Nature, 1992, 358, 36-41.
14. Layer R. T., Popik P., Nowak G., Paul I. A., Trullas R., Skolnick P.: A unified theory of antidepressant action: evidence for adaptation of the N-methyl-D-aspartate (NMDA) receptor following chronic antidepressant treatments. In: Ion Channel Pharmacology. Eds. Cena V., Soria B., Oxford University Press, London, 1995, in press.
15. Łazarewicz J. W., Wróblewski J. T., Palmer M. E., Costa E.: Activation of N-methyl-D-aspartate-sensitive glutamate receptors stimulates arachidonic acid release in primary cultures of cerebellar granule cells. Neuropharmacology, 1988, 27, 765-769.
16. Martin P., Laurent S., Massol J., Childs M., Puech A. J.: Effects of dihydropyridine drugs on reversal by imipramine of helpless behavior in rats. Eur. J. Pharmacol., 1989, 162, 185-188.
17. Meguro H., Mori H., Araki K., Kushiya E., Kutsuwada T., Yamazaki M., Kumanishi T., Arakawa M., Sakimura K., Mishina M.: Functional characterization of a heteromeric NMDA receptor channel from cloned cDNAs. Nature, 1992, 357, 70-74.
18. Mogilnicka E., Czyrak A., Maj J.: Dihydropyridine calcium channel antagonists reduce immobility in the mouse behavioral despair test; antidepressants facilitate nifedipine action. Eur. J. Pharmacol., 1987, 138, 413-416.
19. Mogilnicka E., Czyrak A., Maj J: BAY K 8644 enhances immobility in the mouse behavioral despair test, an effect blocked by nifedipine. Eur. J. Pharmacol., 1988, 151, 307-311.
20. Nahorski S. R., Kendal D. A., Batty I.: Receptors and phosphoinositide metabolism in the central nervous system. Biochem. Pharmacol., 1986, 35, 2447-2453.
21. Novelli A., Nicoletti F., Wróblewski J. T., Alho H., Costa E., Guidotti A.: Excitatory amino acid receptors coupled with guanylate cyclase in primary cultures of cerebellar granule cells. J. Neurosci., 1987, 7, 40-47.
22. Nowak G., Li Y., Paul I. A.: Adaptation of cortical but not hippocampal glutamate-NMDA receptors after chronic citalopram treatment. Eur. J. Pharmacol., 1996, 295, 75-85.
23. +2 antagonists effect an antidepressant-like adaptation of the NMDA receptor complex. Eur. J. Pharmacol. - Molec. Pharm., 1993, 247, 101-102.
24. Nowak G., Trullas R., Layer R. T., Skolnick P., Paul I. A.: Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. J. Pharmacol. Exp. Ther., 1993, 265, 1380-1386.
25. Papp M., Willner P., Muscat R.: An animal model of anhedonia: Attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology, 1991, 104, 255-259.
26. Paul I. A., Layer R. T., Skolnick P., Nowak G.: Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine. Eur. J. Pharmacol. - Molec. Pharm., 1993, 247, 305-311.
27. Paul I. A., Nowak G., Layer R. T., Popik P., Skolnick P.: Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. J. Pharmacol. Exp. Ther., 1994, 269, 95-102.
28. Peunova N., Enikolopov G.: Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells. Nature, 1993, 364, 450-453.
29. Porsolt R. D.: Behavioral despair. In: Antidepressants: Neurochemical, Behavioral and Clinical Perspectives. Eds. Enna S. J., Malik J. B., Richelson E., Raven Press, New York, 1981, 121-139.
30. Pucilowski O.: Psychopharmacological properties of calcium channel inhibitors. Psychopharmacology, 1992, 109, 12-29.
31. Reynolds I. J., Miller R. J.: Multiple sites for the regulation of the N-methy-D-aspartate receptor. Mol. Pharmacol., 1988, 33, 581-584.
32. Sills M. A., Loo P. S.: Tricyclic antidepressants and dextromethorphan bind with higher affinity to the phencyclidine receptor in the absence of magnesium and L-glutamate. Mol. Pharmacol., 1988, 36, 160-165.
33. Skeen G. A., Twyman R. E., White H. S.: The dihydropyridine nitrendipine modulates N-methyl-D-aspartate receptor channel function in mammalian neurons. Mol. Pharmacol., 1993, 44, 443-450.
34. Spedding M., Paoletti R.: Classification of calcium channels and the sites of action of drugs modifying channel function. Pharmacol. Rev., 1992, 44, 363-376.
35. Szekely A. M., Barbaccia B. L., Alho H., Costa E.: In primary cultures of cerebellar granule cells the activation of N-methyl-D-aspartate-sensitive glutamate receptors induces c-fos mRNA expression. Mol. Pharmacol., 1989, 35, 401-108.
36. Trulson M. E., Arasteh K., Ray D. W.: Effects of elevated calcium on learned helplessness and brain serotonin. Pharmacol. Biochem. Behav., 1986, 24, 445-448.
37. Van Riezen H., Leonard B. E.: Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats. In: Psychopharmacology of Anxiolylics and Antidepressants. Ed. File S. E., Pergamon Press, New York, 1991, 231-250.
38. Williams K., Romano C., Dichter M., Molinoff P.: Modulation of the NMDA receptor by polyamines. Life Sci., 1991, 48, 469-198.
39. Willner P.: Animal models of depression: an overview. Pharmacol. Ther., 1990, 45, 425-455.
40. Willner P., Muscat R., Papp M.: Chronic mild stressinduced anhedonia: a realistic animal model of depression. Neurosci. Biobehav. Rev., 1992, 16, 525-534.